PURE Bioscience, Inc.
PURE
$0.0653
$0.00538.83%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -3.30M | -3.35M | -3.63M | -3.65M |
| Total Depreciation and Amortization | 75.00K | 111.00K | 148.00K | 125.00K | 124.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 214.00K | 251.00K | 274.00K | 594.00K | 606.00K |
| Change in Net Operating Assets | 556.00K | 348.00K | 397.00K | 225.00K | 183.00K |
| Cash from Operations | -2.26M | -2.59M | -2.53M | -2.68M | -2.73M |
| Capital Expenditure | -- | -- | -- | 43.00K | 4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 43.00K | 4.00K |
| Total Debt Issued | 1.90M | 1.50M | 1.79M | 2.30M | 1.80M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.90M | 1.50M | 1.79M | 2.30M | 1.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -355.00K | -1.09M | -746.00K | -339.00K | -928.00K |